Bruker (BRKR) Competitors $39.65 -0.07 (-0.18%) As of 11:34 AM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock BRKR vs. WAT, ILMN, TECH, CRL, BIO, PACB, HBIO, TMO, A, and MTDShould you be buying Bruker stock or one of its competitors? The main competitors of Bruker include Waters (WAT), Illumina (ILMN), Bio-Techne (TECH), Charles River Laboratories International (CRL), Bio-Rad Laboratories (BIO), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), Thermo Fisher Scientific (TMO), Agilent Technologies (A), and Mettler-Toledo International (MTD). These companies are all part of the "life sciences tools & services" industry. Bruker vs. Its Competitors Waters Illumina Bio-Techne Charles River Laboratories International Bio-Rad Laboratories Pacific Biosciences of California Harvard Bioscience Thermo Fisher Scientific Agilent Technologies Mettler-Toledo International Bruker (NASDAQ:BRKR) and Waters (NYSE:WAT) are both computer and technology companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, community ranking, dividends, profitability, earnings, analyst recommendations, risk, institutional ownership and media sentiment. Is BRKR or WAT more profitable? Waters has a net margin of 21.56% compared to Bruker's net margin of 3.36%. Waters' return on equity of 46.31% beat Bruker's return on equity.Company Net Margins Return on Equity Return on Assets Bruker3.36% 21.01% 6.46% Waters 21.56%46.31%15.67% Which has preferable earnings and valuation, BRKR or WAT? Waters has lower revenue, but higher earnings than Bruker. Waters is trading at a lower price-to-earnings ratio than Bruker, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBruker$3.45B1.74$113.10M$0.5276.25Waters$2.98B6.90$637.83M$11.0231.37 Which has more risk and volatility, BRKR or WAT? Bruker has a beta of 1.16, indicating that its share price is 16% more volatile than the S&P 500. Comparatively, Waters has a beta of 1.11, indicating that its share price is 11% more volatile than the S&P 500. Does the MarketBeat Community favor BRKR or WAT? Bruker received 239 more outperform votes than Waters when rated by MarketBeat users. Likewise, 64.62% of users gave Bruker an outperform vote while only 53.30% of users gave Waters an outperform vote. CompanyUnderperformOutperformBrukerOutperform Votes68364.62% Underperform Votes37435.38% WatersOutperform Votes44453.30% Underperform Votes38946.70% Do analysts rate BRKR or WAT? Bruker presently has a consensus target price of $56.22, indicating a potential upside of 41.80%. Waters has a consensus target price of $390.19, indicating a potential upside of 12.86%. Given Bruker's higher probable upside, research analysts clearly believe Bruker is more favorable than Waters.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bruker 0 Sell rating(s) 6 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.40Waters 0 Sell rating(s) 9 Hold rating(s) 7 Buy rating(s) 2 Strong Buy rating(s) 2.61 Does the media favor BRKR or WAT? In the previous week, Waters had 27 more articles in the media than Bruker. MarketBeat recorded 34 mentions for Waters and 7 mentions for Bruker. Bruker's average media sentiment score of 1.44 beat Waters' score of 0.19 indicating that Bruker is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bruker 4 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Waters 7 Very Positive mention(s) 3 Positive mention(s) 17 Neutral mention(s) 3 Negative mention(s) 4 Very Negative mention(s) Neutral Do insiders & institutionals have more ownership in BRKR or WAT? 79.5% of Bruker shares are held by institutional investors. Comparatively, 94.0% of Waters shares are held by institutional investors. 27.3% of Bruker shares are held by insiders. Comparatively, 0.8% of Waters shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. SummaryWaters beats Bruker on 11 of the 19 factors compared between the two stocks. Get Bruker News Delivered to You Automatically Sign up to receive the latest news and ratings for BRKR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BRKR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BRKR vs. The Competition Export to ExcelMetricBrukerAnalytical instruments IndustryComputer SectorNASDAQ ExchangeMarket Cap$6.01B$4.58B$26.31B$8.62BDividend Yield0.51%0.55%2.85%4.18%P/E Ratio52.1728.6145.3520.02Price / Sales1.744.041,977.77154.33Price / Cash14.7436.3434.7434.64Price / Book3.351.677.024.70Net Income$113.10M-$84.30M$741.34M$247.97M7 Day Performance5.20%5.74%1.83%2.64%1 Month Performance-1.52%11.18%4.20%6.39%1 Year Performance-40.11%-11.38%52,516.76%13.95% Bruker Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BRKRBruker4.9598 of 5 stars$39.65-0.2%$56.22+41.8%-38.4%$6.01B$3.45B52.178,520Insider TradeWATWaters4.1803 of 5 stars$343.52-1.6%$390.19+13.6%+15.4%$20.44B$2.98B32.078,200Trending NewsILMNIllumina4.8988 of 5 stars$81.09-1.4%$128.15+58.0%-22.2%$12.84B$4.34B-10.5611,500Positive NewsAnalyst ForecastOptions VolumeTECHBio-Techne4.8644 of 5 stars$48.61+0.4%$72.00+48.1%-33.0%$7.62B$1.21B49.103,000CRLCharles River Laboratories International4.735 of 5 stars$134.93-0.5%$171.85+27.4%-28.2%$6.63B$4.02B899.5321,400BIOBio-Rad Laboratories4.7107 of 5 stars$216.69-4.5%$327.40+51.1%-18.1%$5.90B$2.54B-3.338,200News CoverageAnalyst ForecastAnalyst RevisionPACBPacific Biosciences of California2.2462 of 5 stars$0.99+2.5%$2.34+136.8%-36.3%$296.36M$152.36M-0.60730Positive NewsHBIOHarvard Bioscience3.9138 of 5 stars$0.41-13.2%$3.00+640.0%-79.1%$17.92M$91.40M-1.23490Trending NewsShort Interest ↑High Trading VolumeTMOThermo Fisher Scientific4.9756 of 5 stars$396.08-1.7%$607.43+53.4%-27.9%$149.52B$42.90B23.96130,000Positive NewsAAgilent Technologies4.6276 of 5 stars$110.92-0.9%$140.15+26.4%-9.4%$31.62B$6.51B27.3917,900Positive NewsMTDMettler-Toledo International3.7231 of 5 stars$1,138.44-1.5%$1,302.11+14.4%-17.3%$23.66B$3.83B28.0918,000Positive News Related Companies and Tools Related Companies WAT Competitors ILMN Competitors TECH Competitors CRL Competitors BIO Competitors PACB Competitors HBIO Competitors TMO Competitors A Competitors MTD Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BRKR) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bruker Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bruker With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.